Erika Kjellberg Eriksson
InvestorCEO and Chair of the Board at NXT2B
Greater Uppsala Metropolitan Area
Find your path to Erika
220 people in our graph share verified history with Erika — schools, employers, funds. One of them is your warm intro.
About
Erika has over 20 years in the life science sector, previously serving as CFO of OxThera, VP and CFO of Q-Med, and CFO and CEO of BioPhausia. She holds a B.Sc. in Business and Economics from Uppsala University and began her career as an auditor at Ernst & Young.
Contact· self-published, not guessed
Deals · 9
AllgoHolding ABSolo GP
via NXT2B
Hansa Biopharma ABSolo GP
via NXT2B
Lokon Pharma ABSolo GP
via NXT2B
Lumina Adhesives ABSolo GP
via NXT2B
Navinci Diagnostics ABSolo GP
via NXT2B
Q-linea ABSolo GP
via NXT2B
Repos Pharma ABSolo GP
via NXT2B
Scint-X ABSolo GP
via NXT2B
Vivolux ABSolo GP
via NXT2B
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Colleagues at NXT2B
Frequently asked questions
- Who is Erika Kjellberg Eriksson?
- Erika has over 20 years in the life science sector, previously serving as CFO of OxThera, VP and CFO of Q-Med, and CFO and CEO of BioPhausia. She holds a B.Sc. in Business and Economics from Uppsala University and began her career as an auditor at Ernst & Young.
- Where does Erika Kjellberg Eriksson work?
- Erika Kjellberg Eriksson is CEO and Chair of the Board at NXT2B.



